IRS2 and obesity disorder: It has been shown that there is an increased SOCS-1 expression in insulin-sensitive tissues in obesity [87,88] and that this inhibits the phosphorylation of IRS-1 and IRS-2, leading to the inhibition of downstream signaling and insulin resistance [87,88].